Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa)

<div>Cell cycle analysis of MDA-MB-231 cells treated with TQ-NLC for 24 hours and 48 hours, performed by flow cytometer. An increase in the cell population at sub-G1 phase was noted after treatment with 1.56 and 3.125 μM of TQ-NLC.</div>

BioMed Research International

fig6

Figure 6

Figure 6: Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa) 

Figure 6 | Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa) 